Therapy induced tumour secretomes promote resistance and tumour progression
Direct links to NCBI, no account and no request form: the whole study as GSE64741_RAW.tar, processed values as the series matrix, the supplementary file directory, and per-sample supplementary files for any of the 41 samples. Raw sequencing reads are also available from ENA.
Also filed as BioProject PRJNA271773 and SRA study SRP051765. Searching any of these in the dataset finder brings you back here.
The sample list for this study is not cached yet. Press Sort into groups and it will be fetched from NCBI.
+ 41 more — browse all 41 samples with per-sample file links →
- GSE272993 Combination anti-PD-1 and anti-CTLA-4 therapy generates waves of clonal responses that include progenitor-exhausted CD8 T cells [dataset 1] 360 samples
- GSE296419 The critical role of the host endogenous immune compartment after intracerebroventricular CAR T cell therapy in recurrent GBM 143 samples
- GSE229733 Corticosteroid resistance is predetermined by early immune response dynamics at acute Graft-versus-Host disease onset 122 samples
- GSE324062 RAS pathway activation drives clonal selection and monocytic differentiation in FLT3 and BCL2 inhibitor resistance 61 samples
- GSE234654 DDX6 reshapes the cancer RNA editome to suppress RNA-induced innate immunity 57 samples
- GSE333851 Spatial Glyco-Codes Define Human Liver Pathology and Progression 32 samples
- GSE279781 CD137 agonism enhances anti-PD1 induced activation of clonally expanded CD8+ T cells in a neoadjuvant pancreatic cancer clinical trial 30 samples
- GSE250521 A Spatially Resolved Transcriptome Landscape during Thyroid Cancer Progression 25 samples
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.